Veeva Systems announced that Eli Lilly and Company (Lilly) has committed to Veeva Vault CRM globally.
Vault CRM is part of the Vault CRM Suite of applications that provides the technology foundation for agentic commercial, the new commercial model that leverages AI to get the right medicines to more patients.
“We are excited to expand our strategic work with Veeva by moving to Vault CRM,” said Giuseppe Firenze, senior vice president, U.S. HCP and field engagement hub at Lilly. “Vault CRM will help Lilly bring our breakthrough medicines to more patients.”
Marketing Technology News: MarTech Interview with Mark Listes, CEO @ Pendulum Intelligence
“Lilly creates medicines that make life better for people around the world,” said Veeva CEO Peter Gassner. “We are proud to expand our strategic work with Lilly as they roll out Vault CRM globally.”
Veeva delivers the industry cloud for life sciences with applications, agents, data, and consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves.
Marketing Technology News: How MarTech Is Enabling Autonomous Brand Engagement Across Channels?
 has committed to Veeva Vault CRM globally.){kind=link}